NCT01859702View on ClinicalTrials.gov

Pharmacokinetic Evaluation of Moxifloxacin in Vigadexa® in Aqueous Humor Samples Following Preoperative Antibiotic/Steroid Dosing in Cataract Surgery Patients

PHASE4CompletedINTERVENTIONAL

Enrollment

36

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

August 31, 2012

Study Completion Date

August 31, 2012

Conditions

Cataract

Interventions

DRUG

Moxifloxacin 0.5%/Dexamethasone 0.1% ophthalmic solution

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Alcon Research

INDUSTRY

NCT01859702 - Pharmacokinetic Evaluation of Moxifloxacin in Vigadexa® in Aqueous Humor Samples Following Preoperative Antibiotic/Steroid Dosing in Cataract Surgery Patients | Biotech Hunter | Biotech Hunter